Citations

Showing 10 of 108162 citations.

A case of mistaken identity: pseudoaneurysm masquerading as pericardial effusion following premature ventricular contraction ablation
Fritz, Ashley Virginia , Bagameri, Gabor, Bird, Jared, Luis, Sushil A , Luis, Sushil Allen

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | March 4, 2021 | Volume: 22 | Issue: 9 | Pages: e140-e140

10.1093/ehjci/jeab047 | PMID 33712821 Get It

Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers
Przybelski, Scott A. , Lesnick, Timothy G. , Kern, Silke , Blennow, Kaj , Graff‐Radford, Jonathan, Petersen, Ronald C. , Vemuri, Prashanthi , Vemuri, Prashanthi , Mielke, Michelle M. , Zetterberg, Henrik , Knopman, David S. , Graff‐Radford, Jonathan , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | March 4, 2021 | Volume: 17 | Issue: 5 | Pages: 801-812

10.1002/alz.12239 | PMID 33663022 Get It

AbstractIntroductionWe determined whether cerebrospinal fluid (CSF) neurofilament light (NfL), neurogranin (Ng), and total‐tau (t‐tau) differentially mapped to magnetic resonance imaging (MRI) measures of cortical thickness, microstructural integrity (corpus callosum and cingulum fractional anisotropy [FA]), and white matter hyperintensities (WMH).MethodsAnalyses included 536 non‐demented Mayo Clinic Study of Aging participants with CSF NfL, Ng, t‐tau, amyloid beta (Aβ)42 and longitudinal MRI scans. Linear mixed models assessed longitudinal associations between CSF markers and MRI changes.ResultsHigher CSF NfL was associated with decreasing microstructural integrity and WMH. Higher t‐tau was associated with decreasing temporal lobe and Alzheimer's disease (AD) meta region of interest (ROI) cortical thickness. There was no association between Ng and any MRI measure. CSF Aβ42 interacted with Ng for declines in temporal lobe and AD meta ROI cortical thickness and cingulum FA.DiscussionCSF NfL predicts changes in white matter integrity, t‐tau reflects non‐specific changes in cortical thickness, and Ng reflects AD‐specific synaptic and neuronal degeneration.
High-Density EEG in Current Clinical Practice and Opportunities for the Future
Stoyell, Sally M. , Dobrota, Mary-Ann, Chinappen, Dhinakaran M. , Mintz, Mark , Brinkmann, Benjamin H. , Herman, Susan T. , Peters, Jurriaan M. , Seeck, Margitta , Hämäläinen, Matti , Chu, Catherine J. , Brinkmann, Benjamin H , Chu, Catherine J , Wilmskoetter, Janina , Bonilha, Leonardo , Vulliémoz, Serge

Mayo Clinic

Journal of Clinical Neurophysiology | March 4, 2021 | Volume: 38 | Issue: 2 | Pages: 112-123

10.1097/wnp.0000000000000807 | PMID 33661787 Get It

Summary: High-density EEG (HD-EEG) recordings use a higher spatial sampling of scalp electrodes than a standard 10-20 low-density EEG montage. Although several studies have demonstrated improved localization of the epileptogenic cortex using HD-EEG, widespread implementation is impeded by cost, setup and interpretation time, and lack of specific or sufficient procedural billing codes. Despite these barriers, HD-EEG has been in use at several institutions for years. These centers have noted utility in a variety of clinical scenarios where increased spatial resolution from HD-EEG has been required, justifying the extra time and cost. We share select scenarios from several centers, using different recording techniques and software, where HD-EEG provided information above and beyond the standard low-density EEG. We include seven cases where HD-EEG contributed directly to current clinical care of epilepsy patients and highlight two novel techniques which suggest potential opportunities to improve future clinical care. Cases illustrate how HD-EEG allows clinicians to: case 1—lateralize falsely generalized interictal epileptiform discharges; case 2—improve localization of falsely generalized epileptic spasms; cases 3 and 4—improve localization of interictal epileptiform discharges in anatomic regions below the circumferential limit of standard low-density EEG coverage; case 5—improve noninvasive localization of the seizure onset zone in lesional epilepsy; cases 6 and 7—improve localization of the seizure onset zone to guide invasive investigation near eloquent cortex; case 8—identify epileptic fast oscillations; and case 9—map language cortex. Together, these nine cases illustrate that using both visual analysis and advanced techniques, HD-EEG can play an important role in clinical management.
Utility of Ambulatory Surface Electroencephalography
Lhatoo, Samden , Tatum, William O. , Lhatoo, Samden D , Schuele, Stephan

Mayo Clinic

Journal of Clinical Neurophysiology | March 4, 2021 | Volume: 38 | Issue: 2 | Pages: 75-76

10.1097/wnp.0000000000000747 | PMID 33661782 Get It

Ambulatory EEG Usefulness in Epilepsy Management
Hasan, Tasneem F. , Tatum, William O.

Mayo Clinic

Journal of Clinical Neurophysiology | March 4, 2021 | Volume: 38 | Issue: 2 | Pages: 101-111

10.1097/wnp.0000000000000601 | PMID 33661786 Get It

Summary: Long-term video-EEG monitoring has been the gold standard for diagnosis of epileptic and nonepileptic events. Medication changes, safety, and a lack of recording EEG in one's habitual environment may interfere with diagnostic representation and subsequently affect management. Some spells defy standard EEG because of ultradian and circadian times of occurrence, manifest nocturnal expression of epileptiform activity, and require classification for clarifying diagnostic input to identify optimal treatment. Some patients may be unaware of seizures, have frequent events, or subclinical seizures that require quantification before optimal management. The influence on antiseizure drug management and clinical drug research can be enlightened by long-term outpatient ambulatory EEG monitoring. With recent governmental shifts to focus on mobile health, ambulatory EEG monitoring has grown beyond diagnostic capabilities to target the dynamic effects of medical and nonmedical treatment for patients with epilepsy in their natural environment. Furthermore, newer applications in ambulatory monitoring include additional physiologic parameters (e.g., sleep, detection of myogenic signals, etc.) and extend treatment relevance to patients beyond seizure reduction alone addressing comorbid conditions. It is with this focus in mind that we direct our discussion on the present and future aspects of using ambulatory EEG monitoring in the treatment of patients with epilepsy.
Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era
Khurana, Arushi , Novo, Mattia , Nowakowski, Grzegorz S. , Ristow, Kay M., Spinner, Robert J. , King, Rebecca L. , Micallef, Ivana N. , Johnston, Patrick B. , Hunt, Christopher H. , Lachance, Daniel Honore , Habermann, Thomas M.

Mayo Clinic

Blood Advances | March 4, 2021 | Volume: 5 | Issue: 5 | Pages: 1379-1387

10.1182/bloodadvances.2020003666 | PMID 33661298 Get It

AbstractNeurolymphomatosis (NL) is a rare manifestation of lymphoma, with limited evidence for optimal management. The largest patient series, 50 cases of lymphoma and leukemia, was published in 2010 with limited rituximab exposure. This study aims to evaluate the clinical presentation, diagnostic testing, and outcomes of NL in the rituximab era. Forty biopsy-proven cases of NL, in association with non-Hodgkin lymphoma (NHL), at the Mayo Clinic were retrospectively evaluated. B-cell NHL was associated with 97% of NL cases, of which diffuse large B-cell lymphoma (DLBCL) was the most common (68%). Primary NL, defined as neural involvement present at the time of diagnosis of lymphoma, was noted in 52% cases. Seventy percent of patients presented with sensorimotor weakness and neuropathic pain. Magnetic resonance imaging (MRI) was positive in 100% patients. Overall survival (OS) was significantly better for primary NL and NL associated with indolent lymphomas. Relapses were seen in 60% (24/40) of patients; 75% involved the peripheral or central nervous system at relapse. The use of rituximab in the frontline setting significantly impacted progression-free survival (PFS). Transplant consolidation was noted to be associated with improved OS. This study adds to the available literature on NL in the rituximab era. The overall outcomes have improved in recent years. In our experience, MRI and positron emission tomography/computed tomography may be required for accurate assessment of the extent of disease involvement and identification of an optimal biopsy site. The use of rituximab was associated with improvement in PFS, and autologous stem cell transplant was associated with OS.
When Benign Behaves Badly
Caserta, Melanie P. , Fetzer, David T. , Swensson, Jordan , Boyum, James H. , Rodgers, Shuchi K.

Mayo Clinic

Ultrasound Quarterly | March 4, 2021 | Volume: 38 | Issue: 2 | Pages: 133-141

10.1097/ruq.0000000000000555 | PMID 35362690 Get It

Abstract Hemangioma is the most common benign liver tumor and is frequently encountered as an incidental finding on imaging. The classic enhancement pattern of hemangioma is diagnostic on contrast-enhanced ultrasound (CEUS), and it follows the same pattern of enhancement on computed tomography and magnetic resonance imaging. However, there is a subset of hemangiomas that demonstrate atypical enhancement patterns on CEUS. The ability to recognize the different enhancement patterns and discern when additional imaging or biopsy may be necessary is essential to accurately interpret an atypical hemangioma on CEUS. This article reviews various enhancement patterns of hemangioma on CEUS to avoid pitfalls in characterization of focal liver lesions on CEUS.
Epidemiology and Clinical Characteristics of Presumed Ocular Histoplasmosis in Olmsted County, Minnesota
Xu, Timothy T. , Hodge, David O. , Smith, Wendy M. , Smith, Wendy M , Reynolds, Margaret

Mayo Clinic

Ocular Immunology and Inflammation | March 4, 2021 | Volume: 30 | Issue: 5 | Pages: 1039-1043

10.1080/09273948.2020.1859549 | PMID 33661067 Get It

Cardio Phenotypic Potential of Mesenchymal Stem Cells
Franchi, Federico , Olthoff, Michaela , Paulmurugan, Ramasamy , Rodriguez‐Porcel, Martin , Peterson, Karen M. , Rodriguez-Porcel, Martin

Mayo Clinic

Current Protocols | March 4, 2021 | Volume: 1 | Issue: 3 | Pages: No page available

10.1002/cpz1.62 | PMID 33661576 Get It

AbstractCell therapy is being investigated as a powerful intervention to ameliorate the consequences of coronary artery disease. Among the different stem cell options, mesenchymal stem cells (MSCs) are particularly attractive due to their high availability, as well as immune‐privileged status. However, it is still unclear whether mesenchymal stem cells can acquire cardiomyogenic characteristics after they are transplanted to the myocardium. In this article, we outline protocols that illustrate the plasticity of MSCs and their ability to acquire cardiogenic characteristics when they are in an ischemic‐like environment, as typically encountered after transplantation into the ischemic heart. © 2021 Wiley Periodicals LLC.This article was corrected on 26 July 2022. See the end of the full text for details.Basic Protocol 1: Isolation of mesenchymal stem cells (MSCs)Support Protocol 1: Characterization of MSCs by flow cytometryBasic Protocol 2: Isolation of neonatal cardiomyoctes (NCMs)Support Protocol 2: Characterization of NCMsBasic Protocol 3: Cardiogenic plasticity of MSCs under ischemic‐like conditionsSupport Protocol 3: Characterization of the cardiomyogenic potential of MSCs
Development and Pilot Testing of Entrustable Professional Activities for US Anesthesiology Residency Training
Woodworth, Glenn E. , Tanaka, Pedro , Fromer, Ilana R. , Hallman, Matthew R., Klesius, Lisa L. , Ladlie, Beth L., Mitchell, Sally A. , Juve, Amy K. Miller , McGrath, Brian J., Shepler, John A. , Sims, Charles R. , Spofford, Christina M., Maniker, Robert B. , Sims, Charles, Marty, Adrian , Ambardekar, Aditee P. , Chen, Fei , Duncan, Michael Joseph , Cleve, Wil Van

Mayo Clinic

Anesthesia & Analgesia | March 4, 2021 | Volume: 132 | Issue: 6 | Pages: 1579-1591

10.1213/ane.0000000000005434 | PMID 33661789 Get It

BACKGROUND: Modern medical education requires frequent competency assessment. The Accreditation Council for Graduate Medical Education (ACGME) provides a descriptive framework of competencies and milestones but does not provide standardized instruments to assess and track trainee competency over time. Entrustable professional activities (EPAs) represent a workplace-based method to assess the achievement of competency milestones at the point-of-care that can be applied to anesthesiology training in the United States. METHODS: Experts in education and competency assessment were recruited to participate in a 6-step process using a modified Delphi method with iterative rounds to reach consensus on an entrustment scale, a list of EPAs and procedural skills, detailed definitions for each EPA, a mapping of the EPAs to the ACGME milestones, and a target level of entrustment for graduating US anesthesiology residents for each EPA and procedural skill. The defined EPAs and procedural skills were implemented using a website and mobile app. The assessment system was piloted at 7 anesthesiology residency programs. After 2 months, faculty were surveyed on their attitudes on usability and utility of the assessment system. The number of evaluations submitted per month was collected for 1 year. RESULTS: Participants in EPA development included 18 education experts from 11 different programs. The Delphi rounds produced a final list of 20 EPAs, each differentiated as simple or complex, a defined entrustment scale, mapping of the EPAs to milestones, and graduation entrustment targets. A list of 159 procedural skills was similarly developed. Results of the faculty survey demonstrated favorable ratings on all questions regarding app usability as well as the utility of the app and EPA assessments. Over the 2-month pilot period, 1636 EPA and 1427 procedure assessments were submitted. All programs continued to use the app for the remainder of the academic year resulting in 12,641 submitted assessments. CONCLUSIONS: A list of 20 anesthesiology EPAs and 159 procedural skills assessments were developed using a rigorous methodology to reach consensus among education experts. The assessments were pilot tested at 7 US anesthesiology residency programs demonstrating the feasibility of implementation using a mobile app and the ability to collect assessment data. Adoption at the pilot sites was variable; however, the use of the system was not mandatory for faculty or trainees at any site.